Newsroom

Newsroom

Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC)

Literature
Read More

Validation of recurrence prediction using circulating tumor DNA in patients with curatively treated early stage non-small cell lung cancer

Literature
Read More

NeoGenomics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference

Press Release
Read More

NeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay for Molecular Residual Disease and Recurrence Monitoring at ASCO

Press Release
Read More

NeoGenomics Reports First Quarter 2023 Results

Press Release
Read More

NeoGenomics to Participate at the BofA Securities 2023 Healthcare Conference

Press Release
Read More

Spatial Analysis of Genomic Signatures on Colorectal Cancer Pathogenesis Using the NanoString GeoMx® Digital Spatial Profiler

Literature
Read More

Bridging the gap between targeted NGS and FISH gene-level CNV detection capabilities in hematologic malignancies

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients